Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. - Smith MR; Fallon MA; Lee H; Finkelstein JS (The Journal of clinical endocrinology and metabolism, 2004)